Study the Effects of CYP2C Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Glipizide
NCT00806013 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 36
Last updated 2010-01-27
Summary
The aims of this study were to investigate the effects of CYP2C9 and CYP2C19 polymorphisms on the pharmacokinetics and pharmacodynamics of glipizide in healthy Chinese subjects.
Conditions
- Healthy
Sponsors & Collaborators
-
Chinese Academy of Sciences
lead OTHER_GOV
Principal Investigators
-
Bo Tan · Shanghai Institute of Materia Medica, Chinese Academy of Sciences
Eligibility
- Min Age
- 21 Years
- Max Age
- 27 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-08-31
- Completion
- 2008-12-31
Countries
- China
Study Locations
More Related Trials
-
A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of PF-06882961 in Chinese Adults With Type 2 Diabetes Mellitus
NCT04889157 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Pharmacokinetics Study of a New Drug for Type 2 Diabetes
NCT02686281 ·Status: TERMINATED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 14332 CL as Tablet in Female and Male Patients With Type 2 Diabetes
NCT02212925 ·Status: TERMINATED ·Phase: PHASE1
-
The Effectivity and Safety Study of rExenatide-4 in Chinese Type 2 Diabetes Mellitus
NCT03239119 ·Status: UNKNOWN ·Phase: PHASE3
-
To Evaluate the Safety and Pharmacokinetic Characteristics After the Administration of JT-001, JT-002 and JLP-2008
NCT06165965 ·Status: COMPLETED ·Phase: PHASE1
-
Sulphonylurea Receptor Mutation and Responsiveness to Gliclazide - a Pilot Proof of Concept, Randomised Cross-over Study
NCT02201602 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Insulin Sensitizers in Subjects With Impaired Glucose Tolerance
NCT00108615 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Investigate the Glucose Lowering Effects of Dextromethorphan Alone or in Combination With Sitagliptin in Subjects With Type 2 Diabetes Mellitus (T2DM) After an Oral Glucose Tolerance Test
NCT01936025 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacokinetic and Safety Study of GZR4 Injection in Subjects With Hepatic Impairment
NCT07193147 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Efficacy and Safety of Teneligliptin in Combination With Metformin in Chinese Patients With Type 2 Diabetes Mellitus
NCT02924064 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 135585 XX in Patients With Type 2 Diabetes
NCT01282970 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Efficacy and Safety of CJ-30001 and CJ-30002 in Type 2 Diabetes Mellitus Patients
NCT01370707 ·Status: COMPLETED ·Phase: PHASE3
-
To Assess Safety, Tolerability, Pharmacokinetics/Pharmacodynamics and the Effect of Fasting After Single Oral Doses of AZD5658 in Type 2 Diabetes
NCT01176097 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of CKD-501 Versus Pioglitazone When Added to Metformin
NCT01106131 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Anti-diabetic Drugs on Glycemic Variability
NCT02925559 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Assess the Safety and Tolerability After Multiple Oral Doses of AZD1656 in Patients With Type 2 Diabetes Mellitus Treated With Metformin
NCT00817778 ·Status: COMPLETED ·Phase: PHASE2
-
Tolerability to HS-20004 With Titration Administration in Type 2 Diabetic Patients
NCT02750007 ·Status: UNKNOWN ·Phase: PHASE1
-
A Single-dose and Multiple-dose Study to Evaluate the Pharmacokinetics and Pharmacodynamics of DBPR108 Tablets in Type 2 Diabetes Mellitus Patients
NCT05146869 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacogenomics of Thiazolidinediones
NCT01135394 ·Status: COMPLETED ·Phase: NA
-
Molecular Mechanisms of Type 2 Diabetes Mellitus
NCT00816218 ·Status: COMPLETED ·Phase: PHASE4
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HMS5552 in Patients With Type 2 Diabetes
NCT02077452 ·Status: COMPLETED ·Phase: PHASE1
-
Investigate the Effect of AZD1656 on the Pharmacokinetics of Pioglitazone and Vice Versa in Type 2 Diabetes Mellitus
NCT01082120 ·Status: COMPLETED ·Phase: PHASE1
-
Investigation on Safety, Tolerability and Pharmacokinetics of Multiple Doses of NNC0113-0987 in an Oral Formulation in Healthy Subjects
NCT01978613 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate the Safety, Tolerability, and Pharmacokinetics of YG1699（Antidiabetic） in Healthy Chinese Sbjects
NCT05089617 ·Status: COMPLETED ·Phase: PHASE1
-
A Non-Interventional Study To Evaluate Diabetes Related Quality Of Life, Frequency And Impact Of Hypoglycemia In T2DM
NCT01523405 ·Status: COMPLETED